Tianlu Li

Tianlu Li, PhD, is a Genomic Scientist at IMIDomics, with more than 10 years of experience in the field of biochemistry and molecular biology. Her main focus for the last 6 years has been the study of omics data in different types of autoimmune diseases as well as in the context of immune cell differentiation. She joined IMIDomics in 2021 where she will integrate her translational experience in the company with the aim of developing precision medicine. Dr. Li received her Master’s degree in Biomedical Science from the University of Melbourne, Australia, in 2010 and earned her Ph.D from the University of Valencia, Spain, in 2015. Subsequently, she did her post-doctoral training at the Josep Carreras Leukaemia Research Institute, where she studied the identification of epigenetic biomarkers and alterations in molecular pathways of cells of the immune system in the context of autoimmune diseases including systemic sclerosis, rheumatoid arthritis and giant cell vasculitis. During these years, she has participated in numerous national and international projects which resulted in a number of publications in high impact journals.